Patient Engagement Solution Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The patient engagement solution market is expected to witness significant growth in the coming years. In 2024, the market for patient engagement solutions is valued at $21.12 billion and is projected to reach $51.15 billion by 2031, growing at a compound annual growth rate (CAGR) of 13.50%. Patient engagement refers to the collaboration between patients, clinicians, and other stakeholders in the healthcare system to improve health outcomes. Through these solutions, patients have access to their health records, medication details, and dosages, enabling them to manage their healthcare more effectively alongside their consultants. The advantages of patient engagement solutions include cost-effective healthcare, increased patient outreach, fewer complications, reduced hospital readmission rates, shorter hospital stays, and enhanced healthcare quality. However, to motivate patient participation, these strategies require substantial interaction.

Market Drivers

The global patient engagement solution market is being propelled by several key factors. Increased government spending on healthcare and prescription drugs, coupled with the rising use of smartphones in healthcare consulting, are major drivers. Additionally, expanding alliances and investments among stakeholders have significantly impacted the market. Factors such as the growing geriatric population and the prevalence of chronic diseases have also spurred the development of patient engagement solutions globally.

Government regulations and initiatives aimed at enhancing patient-centric care are expected to drive industry growth. Governments worldwide are implementing various regulations and programs to encourage the adoption of patient engagement technologies. The increasing use of cloud-based systems in hospitals and clinics, advancements in wearable health technology, and technological innovations are anticipated to create new opportunities in the market. Moreover, the implementation of value-based healthcare programs leads to better health outcomes, lower healthcare costs, and higher patient satisfaction, contributing to market expansion.

Regional Insights

In terms of the regional market Analysis, North America holds a leading position, with a significant share of the global market. This dominance is expected to continue throughout the forecast period. The demand for patient engagement solutions in Europe also represents a considerable portion of the market.

North America

The North American market for patient engagement solutions is leading due to various factors, including robust healthcare infrastructure and increased adoption of advanced technologies. The U.S., in particular, is the most lucrative market in this region, driven by initiatives to promote patient-centric care and increased flexibility for Medicare to protect telehealth services. The U.S. also authorizes home health services provided by physicians and nurses and increases Medicare payments in hospitals and for medical equipment.

Europe

The adoption of home healthcare management services in Europe is driving the market. Germany, in particular, is a significant contributor due to the availability of advanced patient engagement services that enable technology adaptation. These solutions allow patients to track appointments, pay bills online, and communicate with healthcare providers from home.

Market Restraints

Despite the positive outlook, the market faces several restraints. The significant investment required for implementing patient engagement solutions poses challenges. Existing IT infrastructure in healthcare organizations would need modifications to accommodate cloud-based solutions, especially in hospitals that act as hubs connecting multiple physician labs and clinics.

Technological Advancements

Technological advancements play a crucial role in the growth of the patient engagement solution market. Standalone software solutions account for a major share of the market and are expected to maintain their position due to their reliability, unbiased data, and seamless integration with electronic medical records. These features provide users with real-time clinical intelligence, making them suitable for both clinicians and patients.

Deployment Segmentation

Based on deployment, the market is segmented into cloud and on-premise solutions. On-premise solutions currently hold a larger market share due to the control organizations have over their infrastructure and information. These solutions also ensure that software installation and use are managed internally, improving the overall quality of patient engagement products.

Competitive Analysis

Major companies in the patient engagement solution market are focusing on collaborations and partnerships to enhance their offerings. For instance:

In August 2021, McKesson announced a strategic agreement with Merck to harness real-world evidence for improving patient outcomes and developing cancer treatments.
In February 2021, Humana collaborated with IBM to deploy IBM Watson Assistant for Health Benefits, an AI-enabled virtual agent built on IBM Watson Health Cloud, to provide better member experience and clarity on benefits for Humana Employer Group Members.

Key Players

The key players in the patient engagement solution market include:

Allscripts Healthcare Solutions
McKesson Corporation
Cerner Corporation
Phytel Inc.
Medecision Inc.
Athenahealth, Inc.
Novartis
Roche Holding AG
Bayer
GlaxoSmithKline
IQVIA

Market Segmentation

By Solution:

Software
- oIntegrated Patient Software
- oStandalone Software
Scheduling Software
Billing Software
Secure Messaging Software
Others
Services
- oImplementation and Integration
- oConsulting
- oSupport & Maintenance

By Deployment:

Cloud
On-Premise

By Application:

Health Management
Social Management
Home Healthcare Management
Financial Health Management
Others

By End User:

Patients
Payers
Healthcare Providers
Others

By Region:

North America
Latin America
Europe
East Asia
South Asia Pacific
Middle East and Africa

1. Executive Summary

1.1. Global Patient Engagement Solution Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Economic Overview
- 2.6.1. World Economic Projections
2.7. PESTLE Analysis

3. Global Patient Engagement Solution Market Outlook, 2019-2031

3.1. Global Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Software
    - 3.1.1.1.1. Integrated Patient Software
    - 3.1.1.1.2. Standalone Software
      - 3.1.1.1.2.1. Scheduling Software
      - 3.1.1.1.2.2. Billing Software
      - 3.1.1.1.2.3. Secure Messaging Software
      - 3.1.1.1.2.4. Others
  - 3.1.1.2. Services
    - 3.1.1.2.1. Implementation and Integration
    - 3.1.1.2.2. Consulting
    - 3.1.1.2.3. Support & Maintenance
3.2. Global Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Cloud
  - 3.2.1.2. On Premise
3.3. Global Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Health Management
  - 3.3.1.2. Social Management
  - 3.3.1.3. Home Healthcare Management
  - 3.3.1.4. Financial Health Management
  - 3.3.1.5. Others
3.4. Global Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Patients
  - 3.4.1.2. Payers
  - 3.4.1.3. Healthcare Providers
  - 3.4.1.4. Others
3.5. Global Patient Engagement Solution Market Outlook, by Region, Value (US$ Bn), 2019-2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Patient Engagement Solution Market Outlook, 2019-2031

4.1. North America Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Software
    - 4.1.1.1.1. Integrated Patient Software
    - 4.1.1.1.2. Standalone Software
      - 4.1.1.1.2.1. Scheduling Software
      - 4.1.1.1.2.2. Billing Software
      - 4.1.1.1.2.3. Secure Messaging Software
      - 4.1.1.1.2.4. Others
  - 4.1.1.2. Services
    - 4.1.1.2.1. Implementation and Integration
    - 4.1.1.2.2. Consulting
    - 4.1.1.2.3. Support & Maintenance
4.2. North America Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Cloud
  - 4.2.1.2. On Premise
4.3. North America Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Health Management
  - 4.3.1.2. Social Management
  - 4.3.1.3. Home Healthcare Management
  - 4.3.1.4. Financial Health Management
  - 4.3.1.5. Others
4.4. North America Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Patients
  - 4.4.1.2. Payers
  - 4.4.1.3. Healthcare Providers
  - 4.4.1.4. Others
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 4.5.1.2. U.S. Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 4.5.1.3. U.S. Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 4.5.1.4. U.S. Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 4.5.1.5. Canada Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 4.5.1.6. Canada Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 4.5.1.7. Canada Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 4.5.1.8. Canada Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Patient Engagement Solution Market Outlook, 2019-2031

5.1. Europe Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Software
    - 5.1.1.1.1. Integrated Patient Software
    - 5.1.1.1.2. Standalone Software
      - 5.1.1.1.2.1. Scheduling Software
      - 5.1.1.1.2.2. Billing Software
      - 5.1.1.1.2.3. Secure Messaging Software
      - 5.1.1.1.2.4. Others
  - 5.1.1.2. Services
    - 5.1.1.2.1. Implementation and Integration
    - 5.1.1.2.2. Consulting
    - 5.1.1.2.3. Support & Maintenance
5.2. Europe Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Cloud
  - 5.2.1.2. On Premise
5.3. Europe Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Health Management
  - 5.3.1.2. Social Management
  - 5.3.1.3. Home Healthcare Management
  - 5.3.1.4. Financial Health Management
  - 5.3.1.5. Others
5.4. Europe Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Patients
  - 5.4.1.2. Payers
  - 5.4.1.3. Healthcare Providers
  - 5.4.1.4. Others
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 5.5.1.2. Germany Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 5.5.1.3. Germany Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 5.5.1.4. Germany Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 5.5.1.5. U.K. Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 5.5.1.6. U.K. Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 5.5.1.7. U.K. Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 5.5.1.8. U.K. Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 5.5.1.9. France Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 5.5.1.10. France Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 5.5.1.11. France Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 5.5.1.12. France Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 5.5.1.13. Italy Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 5.5.1.14. Italy Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 5.5.1.15. Italy Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 5.5.1.16. Italy Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 5.5.1.17. Turkey Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 5.5.1.18. Turkey Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 5.5.1.19. Turkey Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 5.5.1.20. Turkey Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 5.5.1.21. Russia Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 5.5.1.22. Russia Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 5.5.1.23. Russia Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 5.5.1.24. Russia Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 5.5.1.25. Rest of Europe Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 5.5.1.26. Rest of Europe Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 5.5.1.27. Rest of Europe Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 5.5.1.28. Rest of Europe Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Patient Engagement Solution Market Outlook, 2019-2031

6.1. Asia Pacific Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Software
    - 6.1.1.1.1. Integrated Patient Software
    - 6.1.1.1.2. Standalone Software
      - 6.1.1.1.2.1. Scheduling Software
      - 6.1.1.1.2.2. Billing Software
      - 6.1.1.1.2.3. Secure Messaging Software
      - 6.1.1.1.2.4. Others
  - 6.1.1.2. Services
    - 6.1.1.2.1. Implementation and Integration
    - 6.1.1.2.2. Consulting
    - 6.1.1.2.3. Support & Maintenance
6.2. Asia Pacific Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Cloud
  - 6.2.1.2. On Premise
6.3. Asia Pacific Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Health Management
  - 6.3.1.2. Social Management
  - 6.3.1.3. Home Healthcare Management
  - 6.3.1.4. Financial Health Management
  - 6.3.1.5. Others
6.4. Asia Pacific Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Patients
  - 6.4.1.2. Payers
  - 6.4.1.3. Healthcare Providers
  - 6.4.1.4. Others
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 6.5.1.2. China Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 6.5.1.3. China Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 6.5.1.4. China Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 6.5.1.5. Japan Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 6.5.1.6. Japan Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 6.5.1.7. Japan Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 6.5.1.8. Japan Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 6.5.1.9. South Korea Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 6.5.1.10. South Korea Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 6.5.1.11. South Korea Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 6.5.1.12. South Korea Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 6.5.1.13. India Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 6.5.1.14. India Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 6.5.1.15. India Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 6.5.1.16. India Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 6.5.1.17. Southeast Asia Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 6.5.1.18. Southeast Asia Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 6.5.1.19. Southeast Asia Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 6.5.1.20. Southeast Asia Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 6.5.1.21. Rest of Asia Pacific Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 6.5.1.22. Rest of Asia Pacific Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 6.5.1.23. Rest of Asia Pacific Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 6.5.1.24. Rest of Asia Pacific Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Patient Engagement Solution Market Outlook, 2019-2031

7.1. Latin America Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Software
    - 7.1.1.1.1. Integrated Patient Software
    - 7.1.1.1.2. Standalone Software
      - 7.1.1.1.2.1. Scheduling Software
      - 7.1.1.1.2.2. Billing Software
      - 7.1.1.1.2.3. Secure Messaging Software
      - 7.1.1.1.2.4. Others
  - 7.1.1.2. Services
    - 7.1.1.2.1. Implementation and Integration
    - 7.1.1.2.2. Consulting
    - 7.1.1.2.3. Support & Maintenance
7.2. Latin America Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
7.3. Latin America Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Health Management
  - 7.3.1.2. Social Management
  - 7.3.1.3. Home Healthcare Management
  - 7.3.1.4. Financial Health Management
  - 7.3.1.5. Others
7.4. Latin America Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Patients
  - 7.4.1.2. Payers
  - 7.4.1.3. Healthcare Providers
  - 7.4.1.4. Others
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 7.5.1.2. Brazil Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 7.5.1.3. Brazil Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 7.5.1.4. Brazil Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 7.5.1.5. Mexico Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 7.5.1.6. Mexico Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 7.5.1.7. Mexico Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 7.5.1.8. Mexico Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 7.5.1.9. Argentina Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 7.5.1.10. Argentina Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 7.5.1.11. Argentina Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 7.5.1.12. Argentina Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 7.5.1.13. Rest of Latin America Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 7.5.1.14. Rest of Latin America Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 7.5.1.15. Rest of Latin America Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 7.5.1.16. Rest of Latin America Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Patient Engagement Solution Market Outlook, 2019-2031

8.1. Middle East & Africa Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Software
    - 8.1.1.1.1. Integrated Patient Software
    - 8.1.1.1.2. Standalone Software
      - 8.1.1.1.2.1. Scheduling Software
      - 8.1.1.1.2.2. Billing Software
      - 8.1.1.1.2.3. Secure Messaging Software
      - 8.1.1.1.2.4. Others
  - 8.1.1.2. Services
    - 8.1.1.2.1. Implementation and Integration
    - 8.1.1.2.2. Consulting
    - 8.1.1.2.3. Support & Maintenance
8.2. Middle East & Africa Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Cloud
  - 8.2.1.2. On Premise
8.3. Middle East & Africa Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Health Management
  - 8.3.1.2. Social Management
  - 8.3.1.3. Home Healthcare Management
  - 8.3.1.4. Financial Health Management
  - 8.3.1.5. Others
8.4. Middle East & Africa Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Patients
  - 8.4.1.2. Payers
  - 8.4.1.3. Healthcare Providers
  - 8.4.1.4. Others
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 8.5.1.2. GCC Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 8.5.1.3. GCC Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 8.5.1.4. GCC Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 8.5.1.5. South Africa Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 8.5.1.6. South Africa Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 8.5.1.7. South Africa Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 8.5.1.8. South Africa Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 8.5.1.9. Egypt Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 8.5.1.10. Egypt Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 8.5.1.11. Egypt Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 8.5.1.12. Egypt Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 8.5.1.13. Nigeria Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 8.5.1.14. Nigeria Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 8.5.1.15. Nigeria Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 8.5.1.16. Nigeria Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
  - 8.5.1.17. Rest of Middle East & Africa Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
  - 8.5.1.18. Rest of Middle East & Africa Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
  - 8.5.1.19. Rest of Middle East & Africa Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
  - 8.5.1.20. Rest of Middle East & Africa Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Market Share Analysis, 2024
9.2. Competitive Dashboard
9.3. Company Profiles
- 9.3.1. Allscripts Healthcare Solutions
  - 9.3.1.1. Company Overview
  - 9.3.1.2. Product Portfolio
  - 9.3.1.3. Financial Overview
  - 9.3.1.4. Business Strategies and Development
- 9.3.2. McKesson Corporation
  - 9.3.2.1. Company Overview
  - 9.3.2.2. Product Portfolio
  - 9.3.2.3. Financial Overview
  - 9.3.2.4. Business Strategies and Development
- 9.3.3. Cerner Corporation
  - 9.3.3.1. Company Overview
  - 9.3.3.2. Product Portfolio
  - 9.3.3.3. Financial Overview
  - 9.3.3.4. Business Strategies and Development
- 9.3.4. Phytel Inc
  - 9.3.4.1. Company Overview
  - 9.3.4.2. Product Portfolio
  - 9.3.4.3. Financial Overview
  - 9.3.4.4. Business Strategies and Development
- 9.3.5. Medecision Inc
  - 9.3.5.1. Company Overview
  - 9.3.5.2. Product Portfolio
  - 9.3.5.3. Financial Overview
  - 9.3.5.4. Business Strategies and Development
- 9.3.6. Athenahealth, Inc.
  - 9.3.6.1. Company Overview
  - 9.3.6.2. Product Portfolio
  - 9.3.6.3. Financial Overview
  - 9.3.6.4. Business Strategies and Development
- 9.3.7. Novartis
  - 9.3.7.1. Company Overview
  - 9.3.7.2. Product Portfolio
  - 9.3.7.3. Financial Overview
  - 9.3.7.4. Business Strategies and Development
- 9.3.8. Roche Holding AG
  - 9.3.8.1. Company Overview
  - 9.3.8.2. Product Portfolio
  - 9.3.8.3. Financial Overview
  - 9.3.8.4. Business Strategies and Development
- 9.3.9. Bayer
  - 9.3.9.1. Company Overview
  - 9.3.9.2. Product Portfolio
  - 9.3.9.3. Financial Overview
  - 9.3.9.4. Business Strategies and Development
- 9.3.10. Others
  - 9.3.10.1. Company Overview
  - 9.3.10.2. Product Portfolio
  - 9.3.10.3. Financial Overview
  - 9.3.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations